Global Demineralized Bone Matrix Market, By Type (Gel, Putty, Putty with Chips, and Others), By Applications (Dental, Spine Surgery, and Trauma Surgery), By End User (Hospitals, Specialty Clinics, and Others), and By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa) is estimated to be valued at US$ 619.5 Mn in 2021 and is expected to exhibit a CAGR of 4.3% during the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key companies in the market are focusing on growth strategies such as product approvals, which is expected to propel growth of over the forecast period. For instance, in August 2015, Xtant Medical Holdings Inc.’s subsidiary, Bacterin International Inc. received FDA 510(k) clearance for OsteoSelect PLUS demineralized bone matrix putty.
Global Demineralized Bone Matrix Market– Impact of Coronavirus (COVID-19) Pandemic
The coronavirus pandemic has affected business and economic activities of various industries globally. The pandemic had a crucial impact on the U.S., Japan, China, and many major European countries. Since most of these countries are major manufacturers of demineralized bone matrix, the pandemic and nationwide lockdowns caused a decline in the business and consumer spending until the end of the 2020. The transportation of raw materials between regions cannot be carried out successfully. This shortage of raw materials and components have affected the supply chain. This, in turn, had a slightly negative impact on the demineralized bone matrix market. However, the global demineralized bone matrix market is focusing to recover in the next one or two years, due to the increasing research for the development of rapid COVID-19 detection tests.
Browse 27 Market Data Tables and 31 Figures spread through 156 Pages and in-depth TOC on “Global Demineralized Bone Matrix Market.”- Forecast to 2028, Global Demineralized Bone Matrix Market, By Type (Gel, Putty, Putty with Chips, and Others), By Applications (Dental, Spine Surgery, and Trauma Surgery), By End User (Hospitals, Specialty Clinics, and Others), and By Region (North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/demineralized-bone-matrix-market-4550
Moreover, increasing product launch and regulatory approval is also expected to aid in growth of the global demineralized bone matrix market over the forecast period. For instance, in November 2017, SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, received 510(k) clearance from the United States Food and Drug Administration (FDA) for its OsteoBallast demineralized bone matrix (DBM) in resorbable mesh.
Key Takeaways of the Global Demineralized Bone Matrix Market:
- The global demineralized bone matrix market.is expected to exhibit a CAGR of 4.3% during the forecast period due to key players focusing on inorganic growth strategies such as acquisition, this is expected to boost the market growth over forecast period. For instance, in November 2020, Stryker completed the acquisition of Wright Medical Group N.V., a global medical device company focused on extremities and biologics. This acquisition is expected to enhance global market position in trauma and extremities, providing significant opportunities to advance innovation and reach out to more patients.
- Among end user, hospitals segment is estimated to hold largest market share in global demineralized bone matrix market over the forecast period. Increasing number of patient population suffering from spinal disorder is expected to drive the segment growth over forecast period. For instance, according to the article published in the National Center for Biotechnology Information in December 2018, more than 2.4 million people in the U.S. are expected to be affected by symptomatic lumbar spinal stenosis in 2021.
- Among the regions, North America estimated to hold dominant position in global demineralized bone matrix market over the forecast period. Key players in the market are focusing on growth strategies such as product launch, this is expected to drive the U.S. demineralized bone matrix market over the forecast period. For instance, in July 2020, Spine Wave completed the limited market release of Tempest Allograft Bone Matrix and its entry into the spinal biologics market.
- Major players operating in the global demineralized bone matrix market are Medtronic Plc, Johnson & Johnson (DePuy Synthes), Exactech, Inc., HansBioMed, Xtant Medical, Stryker, Arthrex GmbH, RTI Surgical, Zimmer Biomet, and Straumann
